|
GLCCI1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.85670000005545E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.204660E-03 |
| Normal-vs-Stage2 |
1.458890E-03 |
| Normal-vs-Stage3 |
1.10840000000501E-06 |
| Normal-vs-Stage4 |
2.07199999999741E-05 |
| Stage1-vs-Stage2 |
2.194800E-01 |
| Stage1-vs-Stage3 |
1.220950E-03 |
| Stage1-vs-Stage4 |
1.654470E-02 |
| Stage2-vs-Stage3 |
2.928200E-01 |
| Stage2-vs-Stage4 |
3.862400E-01 |
| Stage3-vs-Stage4 |
9.880800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.4456000000026E-05 |
| Normal-vs-AfricanAmerican |
6.615200E-03 |
| Normal-vs-Asian |
4.243600E-03 |
| Caucasian-vs-AfricanAmerican |
6.267200E-01 |
| Caucasian-vs-Asian |
7.409600E-01 |
| AfricanAmerican-vs-Asian |
4.883000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.190800E-04 |
| Normal-vs-Female |
4.15249999996536E-06 |
| Male-vs-Female |
3.460400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.698000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.59862999999927E-05 |
| Normal-vs-Age(61-80Yrs) |
1.64209999997667E-06 |
| Normal-vs-Age(81-100Yrs) |
2.1886000000082E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.058000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.819500E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.837100E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.278800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.188200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.039200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.29150000027778E-07 |
| Classical-VS-Follicular |
1.040180E-01 |
| Classical-VS-Other |
8.068000E-01 |
| Classical-VS-Normal |
4.207200E-04 |
| Tall-VS-Follicular |
2.543800E-03 |
| Tall-VS-Other |
6.958400E-02 |
| Tall-VS-Normal |
2.71029998444305E-09 |
| Follicular-VS-Other |
4.552200E-01 |
| Follicular-VS-Normal |
1.022830E-04 |
| Other-VS-Normal |
2.857400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.181620E-04 |
| Normal-vs-N1 |
3.761200E-03 |
| N0-vs-N1 |
9.153800E-01 |
|
|
